Intellipharmaceutics International Inc. (IPCI)

[WeeZuhl]

I heard Purdue loves IPCI's idea.

I still say Purdue is a potential partner. Purdue have openly said they will be looking for new platforms and delivery tech to solve their problem.

Hardshell ADF 12-hour oxycodone. Purdue loves the idea- mainly because they've sold about $20 billion worth of it since 2010. It's called OxyContin, and Rexista is not proven superior in any way to the current version.


Also, Purdue already has their next generation ADF platform. Hysingla ER is 24-hour hydrocodone based on their proprietary Resistic technology. It cruised through AdComm and was approved in 2014 with a complete ADF label, including chewing, snorting, and IV abuse. As soon as they have a reason (i.e. generic OxyContin approvals), Purdue will submit an NDA for their latest version of OxyContin, which I suspect will be 24-hour and also based on Resistic tech.


Plain and simple, Purdue has no use for Rexista or IPCI. And please, people, always remember: Perdue sells chickens, Purdue sells drugs.